Maintenance Infos

Browse by Creators - Zurich Open Repository and Archive

Navigate back| Up a level
Export as
Number of items: 71.

Zbinden, A; Dürig, R; Shah, C; Böni, J; Schüpbach, J (2016). Importance of an Early HIV Antibody Differentiation Immunoassay for Detection of Dual Infection with HIV-1 and HIV-2. PLoS ONE, 11(6):online.

Vetter, Beatrice N; Orlowski, Vanessa; Niederhauser, Christoph; Walter, Louise; Schüpbach, J (2015). Impact of naturally occurring amino acid variations on the detection of HIV-1 p24 in diagnostic antigen tests. BMC Infectious Diseases, 15(468):online.

Vetter, B N; Orlowski, V; Schüpbach, J; Boeni, J; Ruehe, B; Huder, J B (2015). Resolution of plasma sample mix-ups through comparison of patient antibody patterns to E. coli. Journal of Immunological Methods, 427:130-133.

Schüpbach, J; Niederhauser, C; Yerly, S; Regenass, S; Gorgievski, M; Aubert, V; Ciardo, D; Klimkait, T; Dollenmaier, G; Andreutti, C; Martinetti, G; Brandenberger, M; Gebhardt, M D (2015). Decreasing proportion of recent infections among newly diagnosed HIV-1 cases in Switzerland, 2008 to 2013 based on line-immunoassay-based algorithms. PLoS ONE, 10(7):e0131828.

Vetter, B N; Orlowski, V; Fransen, K; Niederhauser, C; Aubert, V; Brandenberger, M; Ciardo, D; Dollenmaier, G; Klimkait, T; Regenass, S; Schmid, P; Schottstedt, V; Suter-Riniker, F; Yerly, S; Shah, C; Böni, J; Schüpbach, J (2014). Generation of a Recombinant Gag Virus-Like-Particle Panel for the Evaluation of p24 Antigen Detection by Diagnostic HIV Test. PLoS ONE, 9(10):e111552-e111552.

Vetter, B N; Shah, C; Huder, J B; Böni, J; Schüpbach, J (2014). Use of reverse-transcriptase-based HIV-1 viral load assessment to confirm low viral loads in newly diagnosed patients in Switzerland. BMC Infectious Diseases, 14:84.

Schüpbach, J (2013). Das schweizerische HIV Testkonzept – eine aktualisierte Übersicht. Bulletin Bundesamt für Gesundheit:6-14.

Schüpbach, J; Gebhardt, M D; Scherrer, A U; Bisset, L R; Niederhauser, C; Regenass, S; Yerly, S; Aubert, V; Suter, F; Pfister, S; Martinetti, G; Andreutti, C; Klimkait, T; Brandenberger, M; Gunthard, H F (2013). Simple estimation of incident HIV infection rates in notification cohorts based on window periods of algorithms for evaluation of line-immunoassay result patterns. PLoS ONE, 8(8):e71662.

Weber, R; Ruppik, M; Rickenbach, M; Spoerri, A; Furrer, H; Battegay, M; Cavassini, M; Calmy, A; Bernasconi, E; Schmid, P; Flepp, M; Kowalska, J; Ledergerber, B; Schmid, P; Schultze, D; Schöni-Affolter, F; Schüpbach, J; Speck, R; Taffé, P; Tarr, P; Telenti, A; Trkola, A; Vernazza, P; Weber, R; Yerly, S (2013). Decreasing mortality and changing patterns of causes of death in the Swiss HIV Cohort Study. HIV Medicine, 14(4):195-207.

Schüpbach, J; Bisset, L R; Gebhardt, M D; Regenass, S; Bürgisser, P; Gorgievski, M; Klimkait, T; Andreutti, C; Martinetti, G; Niederhauser, C; Yerly, S; Pfister, S; Schultze, D; Brandenberger, M; Schöni-Affolter, F; Scherrer, A U; Gunthard, H F (2012). Diagnostic performance of line-immunoassay based algorithms for incident HIV-1 infection. BMC Infectious Diseases, 12(88):1471-2334.

Oufir, M; Bisset, L R; Hoffmann, S R K; Xue, G; Klauser, S; Bergamaschi, B; Gervaix, A; Böni, J; Schüpbach, J; Gutte, B (2011). Artificial 64-residue HIV-1 enhancer-binding peptide is a potent inhibitor of viral replication in HIV-1-infected cells. Advances in Virology, 2011:165871.

Schüpbach, J; Bisset, L R; Regenass, S; Bürgisser, P; Gorgievski, M; Steffen, I; Andreutti, C; Martinetti, G; Shah, C; Yerly, S; Klimkait, T; Gebhardt, M; Schöni-Affolter, F; Rickenbach, M (2011). High specificity of line-immunoassay based algorithms for recent HIV-1 infection independent of viral subtype and stage of disease. BMC Infectious Diseases, 11(1):254.

Clerc, O; Cavassini, M; Böni, J; Schüpbach, J; Bürgisser, P (2009). Prolonged seroconversion in an elite controller of HIV-1 infection. Journal of Clinical Virology, 46(4):371-373.

Günthard, H F; Huber, M; Kuster, H; Shah, C; Schüpbach, J; Trkola, A; Böni, J (2009). HIV-1 superinfection in an HIV-2-infected woman with subsequent control of HIV-1 plasma viremia. Clinical Infectious Diseases, 48(11):e117-e120.

Daneel, S; Schüpbach, J; Gebhardt, M; Werner, M; Staub, R; Vernazza, P (2008). A prospective evaluation of the feasibility and utility of additional tools to obtain information from recently diagnosed HIV infected patients. Swiss Medical Weekly, 138(31-32):453-458.

Erikstrup, C; Kallestrup, P; Zinyama-Gutsire, R B; Gomo, E; Lüneborg-Nielsen, M; Gerstoft, J; Schüpbach, J; Ullum, H; Katzenstein, T L (2008). p24 as a predictor of mortality in a cohort of HIV-1-infected adults in rural Africa. JAIDS Journal of Acquired Immune Deficiency Syndromes, 48(3):345-349.

Schüpbach, J; Gebhardt, M D; Tomasik, Z; Niederhauser, C; Yerly, S; Bürgisser, P; Matter, L; Gorgievski, M; Dubs, R; Schultze, D; Steffen, I; Andreutti, C; Martinetti, G; Güntert, B; Staub, R; Daneel, S; Vernazza, P (2007). Assessment of recent HIV-1 infection by a line immunoassay for HIV-1/2 confirmation. PLoS Medicine, 4(12):e343.

Yerly, S; von Wyl, V; Ledergerber, B; Böni, J; Schüpbach, J; Bürgisser, P; Klimkait, T; Rickenbach, M; Kaiser, L; Günthard, H F; Perrin, L (2007). Transmission of HIV-1 drug resistance in Switzerland: a 10-year molecular epidemiology survey. AIDS, 21(16):2223-2229.

Knuchel, M C; Jullu, B; Shah, C; Tomasik, Z; Stoeckle, M P; Speck, R F; Nadal, D; Mshinda, H; Böni, J; Tanner, M; Schüpbach, J (2007). Adaptation of the Ultrasensitive HIV-1 p24 Antigen Assay to Dried Blood Spot Testing. Journal of Acquired Immune Deficiency Syndromes, 44(3):247-253.

Bisset, L R; Böni, J; Lutz, H; Schüpbach, J (2007). Lack of evidence for PERV expression after apoptosis-mediated horizontal gene transfer between porcine and human cells. Xenotransplantation, 14(1):13-24.

Sendi, P; Günthard, H F; Simcock, M; Ledergerber, B; Schüpbach, J; Battegay, M (2007). Cost-Effectiveness of Genotypic Antiretroviral Resistance Testing in HIV-Infected Patients with Treatment Failure. PLoS ONE, 2(1):e173.

Tehe, A; Maurice, C; Hanson, D L; Borget, M Y; Abiola, N; Maran, M; Yavo, D; Tomasik, Z; Böni, J; Schüpbach, J; Nkengasong, J N (2006). Quantification of HIV-1 p24 by a highly improved ELISA: An alternative to HIV-1 RNA based treatment monitoring in patients from Abidjan, Côte d'Ivoire. Journal of Clinical Virology, 37(3):199-205.

Schüpbach, J; Tomasik, Z; Knuchel, M C; Opravil, M; Günthard, H F; Nadal, D; Böni, J (2006). Optimized virus disruption improves detection of HIV-1 p24 in particles and uncovers a p24 reactivity in patients with undetectable HIV-1 RNA under long-term HAART. Journal of Medical Virology, 78(8):1003-1010.

Böni, J; Schüpbach, J; Rickenbach, M (2006). Rabbit retrotransposon sequences undetectable in blood donors and lymphoma patients of the Swiss HIV Cohort Study. AIDS Research and Human Retroviruses, 22(6):499-500.

Seemayer, C A; Böni, J; Steiger, J; Schüpbach, J; Mihatsch, M J (2006). No indication for activation of exogenous retroviruses in patients with renal allograft rejection. Clinical Nephrology, 65(5):324-327.

Knuchel, M C; Tomasik, Z; Speck, R F; Lüthy, R; Schüpbach, J (2006). Ultrasensitive quantitative HIV-1 p24 antigen assay adapted to dried plasma spots to improve treatment monitoring in low-resource settings. Journal of Clinical Virology, 36(1):64-67.

Brinkhof, M W G; Böni, J; Steiner, F; Tomasik, Z; Nadal, D; Schüpbach, J (2006). Evaluation of p24-based antiretroviral treatment monitoring in pediatric HIV-1 infection: prediction of the CD4+ T-cell changes between consecutive visits. JAIDS Journal of Acquired Immune Deficiency Syndromes, 41(5):557-562.

Simcock, M; Sendi, P; Ledergerber, B; Keller, T; Schüpbach, J; Battegay, M; Günthard, H F (2006). A longitudinal analysis of healthcare costs after treatment optimization following genotypic antiretroviral resistance testing: does resistance testing pay off? Antiviral Therapy, 11(3):305-314.

Jennings, C; Fiscus, S A; Crowe, S M; Danilovic, A D; Morack, R J; Scianna, S; Cachafeiro, A; Brambilla, D J; Schüpbach, J; Stevens, W; Respess, R; Varnier, O E; Corrigan, G E; Gronowitz, J S; Ussery, M A; Bremer, J W (2005). Comparison of two human immunodeficiency virus (HIV) RNA surrogate assays to the standard HIV RNA assay. Journal of Clinical Microbiology, 43(12):5950-5956.

Schüpbach, J; Günthard, H F; Joos, B; Fischer, M B; Böni, J; Tomasik, Z; Yerly, S; Perrin, L; Battegay, M; Furrer, H; Vernazza, P; Bernasconi, E; Hirschel, B (2005). HIV-1 p24 may persist during long-term highly active antiretroviral therapy, increases little during short treatment breaks, and its rebound after treatment stop correlates with CD4(+) T cell loss. JAIDS Journal of Acquired Immune Deficiency Syndromes, 40(3):250-256.

Deichmann, M; Huder, J B; Kleist, C; Näher, H; Schüpbach, J; Böni, J (2005). Detection of reverse transcriptase activity in human melanoma cell lines and identification of a murine leukemia virus contaminant. Archives of Dermatological Research, 296(8):345-352.

Schüpbach, J (2004). SHCS und die Labordiagnostik der HIV-Infektion - von der Entwicklung des HIV Western Blot über die Virusquantifizierung zur klinisch relevanten individuellen Viruscharakterisierung. Therapeutische Umschau, 61(10):603-607.

Hofmann-Lehmann, R; Meli, M L; Dreher, U M; Gönczi, E; Deplazes, P; Braun, U; Engels, M; Schüpbach, J; Jörger, K; Thoma, R; Griot, C; Stärk, K D C; Willi, B; Schmidt, J; Kocan, K M; Lutz, H (2004). Concurrent infections with vector-borne pathogens associated with fatal hemolytic anemia in a cattle herd in Switzerland. Journal of Clinical Microbiology, 42(8):3775-3780.

Shah, C A; Huder, J B; Böni, J; Schönmann, M; Mühlherr, J; Lutz, H; Schüpbach, J (2004). Direct evidence for natural transmission of small-ruminant lentiviruses of subtype A4 from goats to sheep and vice versa. Journal of Virology, 78(14):7518-7522.

Shah, C A; Böni, J; Huder, J B; Vogt, H R; Mühlherr, J; Zanoni, R; Miserez, R; Lutz, H; Schüpbach, J (2004). Phylogenetic analysis and reclassification of caprine and ovine lentiviruses based on 104 new isolates: evidence for regular sheep-to-goat transmission and worldwide propagation through livestock trade. Virology, 319(1):12-26.

Böni, J; Bisset, L R; Burckhardt, J J; Joller-Jemelka, H I; Bürgisser, P; Perrin, L; Gorgievski, M; Erb, P; Fierz, W; Piffaretti, J C; Schüpbach, J (2004). Prevalence of human T-cell leukemia virus types I and II in Switzerland. Journal of Medical Virology, 72(2):328-337.

Böni, J; Shah, C A; Flepp, M; Lüthy, R; Schüpbach, J (2004). Detection of low copy numbers of HIV-1 proviral DNA in patient PBMCs by a high-input, sequence-capture PCR (Mega-PCR). Journal of Medical Virology, 72(1):1-9.

Schüpbach, J (2003). Viral RNA and p24 antigen as markers of HIV disease and antiretroviral treatment success. International Archives of Allergy and Immunology, 132(3):196-209.

Haupts, S; Ledergerber, B; Böni, J; Schüpbach, J; Kronenberg, A; Opravil, M; Flepp, M; Speck, R F; Grube, C; Rentsch, K; Weber, R; Günthard, H F (2003). Impact of genotypic resistance testing on selection of salvage regimen in clinical practice. Antiviral Therapy, 8(5):443-454.

Ribas, S G; Ondoa, P; Schüpbach, J; van der Groen, G; Fransen, K (2003). Performance of a quantitative human immunodeficiency virus type 1 p24 antigen assay on various HIV-1 subtypes for the follow-up of human immunodeficiency type 1 seropositive individuals. Journal of Virological Methods, 113(1):29-34.

Schüpbach, J; Böni, J; Bisset, L R; Tomasik, Z; Fischer, M; Günthard, H F; Ledergerber, B; Opravil, M (2003). HIV-1 p24 antigen is a significant inverse correlate of CD4 T-cell change in patients with suppressed viremia under long-term antiretroviral therapy. JAIDS Journal of Acquired Immune Deficiency Syndromes, 33(3):292-299.

Shah, C A; Böni, J; Bisset, L R; Seebach, J D; Schüpbach, J (2003). Ultra-sensitive and specific detection of porcine endogenous retrovirus (PERV) using a sequence-capture real-time PCR approach. Journal of Virological Methods, 109(2):209-216.

Hasse, B; Hummel, Y; Böni, J; Schüpbach, J; Flepp, M; Günthard, H F (2003). 25-jähriger therapienaiver Patient mit einem dreiklassenresistenten HI-Virus. Praxis, 92(13):601-605.

Sterling, T R; Hoover, D R; Astemborski, J; Vlahov, D; Bartlett, J G; Schüpbach, J (2002). Heat-denatured human immunodeficiency virus type 1 protein 24 antigen: prognostic value in adults with early-stage disease. Journal of Infectious Diseases, 186(8):1181-1185.

Seemayer, C A; Kolb, S A; Neidhart, M; Ohshima, S; Gay, R E; Michel, B A; Gay, S; Böni, J; Schüpbach, J (2002). Absence of inducible retroviruses from synovial fibroblasts and synovial fluid cells of patients with rheumatoid arthritis. Arthritis and Rheumatism, 46(16):2811-2813.

Minder, D; Böni, J; Schüpbach, J; Gehring, H (2002). Immunophilins and HIV-1 infection. Archives of Virology, 147(8):1531-1542.

Schüpbach, J (2002). Measurement of HIV-1 p24 antigen by signal-amplification-boosted ELISA of heat-denatured plasma is a simple and inexpensive alternative to tests for viral RNA. AIDS Reviews, 4(2):83-92.

Schüpbach, J; Böni, J; Flepp, M; Tomasik, Z; Joller, H; Opravil, M (2001). Antiretroviral treatment monitoring with an improved HIV-1 p24 antigen test: an inexpensive alternative to tests for viral RNA. Journal of Medical Virology, 65(2):225-232.

Bisset, L R; Bosbach, S; Tomasik, Z; Lutz, H; Schüpbach, J; Böni, J (2001). Quantification of in vitro retroviral replication using a one-tube real-time RT-PCR system incorporating direct RNA preparation. Journal of Virological Methods, 91(2):149-155.

Schüpbach, J (2001). Induction/activation and detection of occult viral agents present in mammalian cells. In: Brown, F; Lewis, A M; Peden, K; Krause, P. Evolving Scientific and Regulatory Perspectives on Cell Substrates for Vaccine Development. Basel: Karger, 425-437.

Schüpbach, J; Tomasik, Z; Nadal, D; Ledergerber, B; Flepp, M; Opravil, M; Böni, J (2000). Use of HIV-1 p24 as a sensitive, precise and inexpensive marker for infection, disease progression and treatment failure. International Journal of Antimicrobial Agents, 16(4):441-445.

Ledergerber, B; Flepp, M; Böni, J; Tomasik, Z; Cone, R W; Lüthy, R; Schüpbach, J (2000). Human immunodeficiency virus type 1 p24 concentration measured by boosted ELISA of heat-denatured plasma correlates with decline in CD4 cells, progression to AIDS, and survival: comparison with viral RNA measurement. Journal of Infectious Diseases, 181(4):1280-1288.

Bürgisser, P; Vernazza, P; Flepp, M; Böni, J; Tomasik, Z; Hummel, U; Pantaleo, G; Schüpbach, J (2000). Performance of five different assays for the quantification of viral load in persons infected with various subtypes of HIV-1. Swiss HIV Cohort Study. JAIDS Journal of Acquired Immune Deficiency Syndromes, 23(2):138-144.

Böni, J; Pyra, H; Gebhardt, M; Perrin, L; Bürgisser, P; Matter, L; Fierz, W; Erb, P; Piffaretti, J C; Minder, E; Grob, P; Burckhardt, J J; Zwahlen, M; Schüpbach, J (1999). High frequency of non-B subtypes in newly diagnosed HIV-1 infections in Switzerland. JAIDS Journal of Acquired Immune Deficiency Syndromes, 22(2):174-179.

Nadal, D; Böni, J; Kind, C; Varnier, O E; Steiner, F; Tomasik, Z; Schüpbach, J (1999). Prospective evaluation of amplification-boosted ELISA for heat-denatured p24 antigen for diagnosis and monitoring of pediatric human immunodeficiency virus type 1 infection. Journal of Infectious Diseases, 180(4):1089-1095.

Holznagel, E; Hofmann-Lehmann, R; Leutenegger, C M; Allenspach, K; Huettner, S; Forster, U; Niederer, E; Joller, H; Willett, B J; Hummel, U; Rossi, G L; Schüpbach, J; Lutz, H (1998). The role of in vitro-induced lymphocyte apoptosis in feline immunodeficiency virus infection: correlation with different markers of disease progression. Journal of Virology, 72(11):9025-9033.

Schüpbach, J; Böni, J (1998). Sensitivity of heat-denatured p24 antigen in the diagnosis of pediatric HIV infection. Journal of Acquired Immune Deficiency Syndromes, 18(4):399-400.

Schüpbach, J (1998). Xenotransplantation and viruses - the model of retroviruses. Swiss Medical Weekly, 128(24):935-943.

Kind, C; Rudin, C; Siegrist, C A; Wyler, C A; Biedermann, K; Lauper, U; Irion, O; Schüpbach, J; Nadal, D (1998). Prevention of vertical HIV transmission: additive protective effect of elective Cesarean section and zidovudine prophylaxis. Swiss Neonatal HIV Study Group. AIDS, 12(2):205-210.

Conrad, B; Weissmahr, R N; Böni, J; Arcari, R; Schüpbach, J; Mach, B (1997). A human endogenous retroviral superantigen as candidate autoimmune gene in type I diabetes. Cell, 90(2):303-313.

Böni, J; Opravil, M; Tomasik, Z; Rothen, M; Bisset, L; Grob, P J; Lüthy, R; Schüpbach, J (1997). Simple monitoring of antiretroviral therapy with a signal-amplification-boosted HIV-1 p24 antigen assay with heat-denatured plasma. AIDS, 11(6):F47-F52.

Weissmahr, R N; Schüpbach, J; Böni, J (1997). Reverse transcriptase activity in chicken embryo fibroblast culture supernatants is associated with particles containing endogenous avian retrovirus EAV-0 RNA. Journal of Virology, 71(4):3005-3012.

Schüpbach, J; Flepp, M; Pontelli, D; Tomasik, Z; Lüthy, R; Böni, J (1996). Heat-mediated immune complex dissociation and enzyme-linked immunosorbent assay signal amplification render p24 antigen detection in plasma as sensitive as HIV-1 RNA detection by polymerase chain reaction. AIDS, 10(10):1085-1090.

Schüpbach, J; Pyra, H; Jendis, J; Tomasik, Z; Böni, J (1996). Isolation of an in vitro transmissible agent with reverse transcriptase activity from a blood donor with a borderline-positive HIV-1 serology for more than five years. Clinical and Diagnostic Virology, 5(2-3):197-203.

Schüpbach, J (1996). Licencing of diagnostic HIV kits-to keep a sensible standpoint in an area of permanent revolution. Clinical and Diagnostic Virology, 5(2-3):137-146.

Böni, J; Pyra, H; Schüpbach, J (1996). Sensitive detection and quantification of particle-associated reverse transcriptase in plasma of HIV-1-infected individuals by the product-enhanced reverse transcriptase (PERT) assay. Journal of Medical Virology, 49(1):23-28.

Böni, J; Stalder, J; Reigel, F; Schüpbach, J (1996). Detection of reverse transcriptase activity in live attenuated virus vaccines. Clinical and Diagnostic Virology, 5(1):43-53.

Pyra, H; Böni, J; Schüpbach, J (1994). Ultrasensitive retrovirus detection by a reverse transcriptase assay based on product enhancement. Proceedings of the National Academy of Sciences of the United States of America (PNAS), 91(4):1544-1548.

Böni, J; Schüpbach, J (1993). Sensitive and quantitative detection of PCR-amplified HIV-1 DNA products by an enzyme linked immunoassay following solution hybridization with two differently labelled oligonucleotide probes. Molecular and Cellular Probes, 7(5):361-371.

Böni, J; Emmerich, B S; Leib, S L; Wiestler, O D; Schüpbach, J; Kleihues, P (1993). PCR identification of HIV-1 DNA sequences in brain tissue of patients with AIDS encephalopathy. Neurology, 43(9):1813-1817.

Schüpbach, J; Böni, J (1993). Quantitative and sensitive detection of immune-complexed and free HIV antigen after boiling of serum. Journal of Virological Methods, 43(2):247-256.

This list was generated on Mon Jul 24 07:19:32 2017 CEST.